Healthcare

Peripheral Artery Disease Market

By Segment, By Region, And Segment Forecasts, 2016 – 2025

Vertical: HealthcareBase Year: 201811 Sections

Executive Summary

Peripheral Artery Disease Market — Snapshot

  • Market Size (2016)

    2016

    $15.29B

  • Projected (2025)

    2025

    $23.62B

  • CAGR (2016–2025)

    5.0%

    5.0%
  • Key Players

    107+

Peripheral artery diseases (PAD) are the diseases of the blood vessels located outside the brain and heart. PAD occurs when plaque builds up in the arteries that carry blood to the head, organs, and limbs. Plaque is made of fat, cholesterol, calcium, fibrous tissue, and other substances in the blood. PAD usually affects the arteries in the legs, but it also can affect the arteries that carry blood from the heart to the head, arms, kidneys, and stomach.

Factors such as rapid growth in the geriatric population and the subsequent increase in the prevalence of peripheral artery diseases, along with increasing product approvals, are driving the growth of the peripheral artery disease market. Additionally, rising cases of diabetes are also driving the growth of the peripheral artery disease market. However, product recalls, and failures are hampering the market growth.

Key Insight

The Peripheral Artery Disease Market market is projected to grow at a CAGR of 5.0% from 2016 to 2025.

Market Performance Trend

Historical performance and future projections (2020–2030, USD Billion)

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Market Scope & Coverage

What this report covers

  • Geographic Coverage: This analysis covers 5 regions: Middle East and Africa, North America, Asia Pacific, Europe, South America.
  • Market Segmentation: The market is analyzed across 3 segments: Hospitals and Clinics, Ambulatory Surgery Centers, End User_Others. Forecasts are provided for each segment from 2016 to 2025.
  • Competitive Landscape: 107 leading companies are profiled, covering market positioning, strategies, and recent developments.

Market Size (USD Mn)

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Market Overview

Peripheral Artery Disease Market — Growth Trajectory

Scope of the Study

The scope of the global peripheral artery disease market study includes market size analysis and a detailed analysis of the manufacturer’s products and strategies. The market has been segmented based on treatment type, end user, and region.

Research Objective

To provide a comprehensive analysis of the global peripheral artery disease market and its sub-segments, thereby providing a detailed structure of the industry To provide detailed insights into factors driving and restraining the growth of the global peripheral artery disease marketTo estimate the market size of the global peripheral artery disease market where 2016 to 2017 would be the historic period, 2018 shall be the base year, and 2019 to 2025 will be the forecast period for the studyTo provide region-wise market value analysis for various segments of the global peripheral artery disease marketTo provide strategic profiling of key companies (manufacturers and distributors) present across the globe and comprehensively analyze their competitiveness/competitive landscape in this market To provide a distribution chain analysis/value chain for the global peripheral artery disease market

Peripheral Artery Disease Market — Growth Trajectory

Hospitals and Clinics
Ambulatory Surgery Centers

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Market Size Trend (USD Mn)

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Market Dimensions

How this market is segmented

  • End User End User is broken down into: Hospitals and Clinics, Ambulatory Surgery Centers, End User_Others.
  • DEVICES DEVICES is broken down into: Angioplasty Balloon, Angioplasty Stents (Stenting), Catheters, Plaque Modification Devices (Atherectomy), Hemodynamic Flow Alteration Devices, Others.
  • Drugs Drugs is broken down into: Lipid-Lowering Drugs, Blood Pressure Lowering Drugs, Glucose Regulating DrugsDrugs, Blood Clot Preventing Drugs.

Geographic Analysis

Regional market breakdown

  • Middle East and Africa Middle East and Africa market size reached $946.26M in 2016 and is projected to reach $1.34B by 2025, growing at a CAGR of 3.9%.
  • North America North America market size reached $5.05B in 2016 and is projected to reach $7.81B by 2025, growing at a CAGR of 5.0%.
  • Asia Pacific Asia Pacific market size reached $3.14B in 2016 and is projected to reach $5.14B by 2025, growing at a CAGR of 5.6%.
  • Europe Europe market size reached $4.84B in 2016 and is projected to reach $7.35B by 2025, growing at a CAGR of 4.7%.
  • South America South America market size reached $1.31B in 2016 and is projected to reach $1.99B by 2025, growing at a CAGR of 4.7%.

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Research Methodology

Peripheral Artery Disease Market — How We Researched This Market

This report applies a rigorous multi-stage research process combining primary interviews, secondary data sources, and bottom-up market modelling to ensure accuracy and completeness across all segments and geographies.

  • Base Year

    2018

  • Historical Period

    2016 – 2018

  • Forecast Period

    2018 – 2025

  • Primary Interviews

    150+

Research Process

Historical data (2016–2018) and forecast period (2018–2025)

1

Problem Definition

  • Market scoping
  • Objective setting
  • Framework design
2

Secondary Research

  • Literature review
  • Data mining
  • Trend analysis
3

Primary Research

  • Expert interviews
  • Field visits
  • Surveys
4

Data Analysis

  • Quantitative modeling
  • Statistical testing
  • Validation
5

Insights & Reporting

  • Synthesis
  • Recommendations
  • Visualization

Research Depth

Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.

Historical vs. Forecast Data

Historical (observed)
Forecast (modelled)

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Competitive Landscape & Porter's Five Forces

Peripheral Artery Disease Market — Competitive Analysis

Threat of New Entrants

There are some mandatory regulatory standards to enter into the drugs and devices market. The threat of new entrants is medium in the peripheral artery disease market. The brand loyalty is medium in the peripheral artery disease market and there many established players in the market, which creates difficulties for newcomers to enter this market.

Bargaining Power of Suppliers

In the global peripheral artery disease market, suppliers are raw materials manufacturers for drug manufacturing companies. The bargaining power of suppliers is low as there is a high number of suppliers in the peripheral artery disease market. Additionally, the switching cost is low as no supplier can influence the prices and exercise control in the industry, which makes the bargaining power low.

Threat of Substitutes

The threat of substitutes in the global peripheral artery disease market is low because of the advantages that peripheral artery disease devices offer. Additionally, quality and trust issues and excellent service provided by the existing players restrict the threat by the substitutes. Also, the low-medium degree of switching costs may minimize the threat of substitutes.

Bargaining Power of Buyers

The bargaining power of buyers is moderate in the global peripheral artery disease market. The presence of buyers in the market is growing due to the increasing awareness about the different products, along with the rising prevalence of peripheral artery diseases. Additionally, the presence of providers is also increasing, which makes the bargaining power of buyers moderate due to the low switching costs.

Intensity of Rivalry

The degree of competition in the global peripheral artery disease market is considered to be medium to high. Differentiation among existing players and the introduction of the newer products is increasing the intensity of rivalry in the market. Peripheral artery disease drugs and device manufacturing companies are trying to develop products with high quality, services, and enhanced safety to increase the demand for these products in developed countries and developing regions. Players are engaged in partnering with established organizations and welcoming tie-ups to overcome the competition. Moreover, the players are also developing advanced products for differentiating their brand from competitors.

Quantitative Analysis

Regional Breakdown

Regional market breakdown for Peripheral Artery Disease Market.

Regional Market Size (USD Mn)

Market estimates by geography (2025)

USD Mn

InsightNorth America leads with $7.81B by 2025, while Asia Pacific is projected to grow fastest at a 5.6% CAGR.

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Regional Market Data

REGION201620182025CAGRSHARE
Middle East and Africa$946.26M$1.21B$1.34B3.9%6%
North America$5.05B$6.56B$7.81B5.0%33%
Asia Pacific$3.14B$3.92B$5.14B5.6%22%
Europe$4.84B$6.24B$7.35B4.7%31%
South America$1.31B$1.71B$1.99B4.7%8%
Total$15.29B$19.64B$23.62B5.0%100%

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Segment Revenue (2025)

Hospitals and Clinics
Ambulatory Surgery Centers
End User_Others
030836166924912332

Segment Market Share

  • Hospitals and Clinics47%
  • Ambulatory Surgery Centers37%
  • End User_Others15%

Total Market Size

$23.62B

Market by Segment (2025)

APPLICATIONREVENUE ($B)GROWTH RATEMARKET PENETRATION
Hospitals and Clinics$11.21B5.0%
81%
Ambulatory Surgery Centers$8.77B5.0%
78%
End User_Others$3.64B5.0%
72%

* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans
Empower your Business
with Insights

Save over 20% on
Annual Subscription

See plans for professionals or small and medium businesses.

Wantstats analytics dashboard

Analytics

Peripheral Artery Disease Market — Key Findings

Analytical insights on Peripheral Artery Disease Market covering market dynamics, competitive landscape, and strategic outlook.

Key Analytical Findings

The Peripheral Artery Disease Market market is projected to reach $23.62B by 2025, growing at 5.0% CAGR. The Hospitals and Clinics segment holds the largest share.

Market Dynamics

Peripheral artery diseases (PAD) are the diseases of the blood vessels located outside the brain and heart. PAD occurs when plaque builds up in the arteries that carry blood to the head, organs, and limbs. Plaque is made of fat, cholesterol, calcium, fibrous tissue, and other substances in the blood. PAD usually affects the arteries in the legs, but it also can affect the arteries that carry blood from your heart to your head, arms, kidneys, and stomach.

Factors such as rapid growth in the geriatric population and the subsequent increase in the prevalence of peripheral artery diseases, along with increasing product approvals, are driving the growth of the peripheral artery disease market. Additionally, rising cases of diabetes are also driving the growth of the peripheral artery disease market. However, product recalls and failures are hampering the market growth.

Likewise, growth in emerging markets would serve as an opportunity for market growth.

Market Drivers

The aging population is highly prone to degenerative diseases and chronic illnesses which eventually leads to a rise in diagnosis and treatment. PAD is caused due to buildup of plaque that causes arteries to narrow which eventually limits the flow of oxygen-rich blood to organs and other parts of the body. According to a study by the American Heart Association in 2016, the prevalence of PAD was 6.6% in patients aged 55 to 59 and was about 59.6% in patients aged 85 years or older in the US. The prevalence of PAD affects approximately 5 to 10 million Americans and is a leading cause of disability among people more than 50 years and those with diabetes in the US. According to the National Center for Biotechnology Information, the prevalence of PAD increases with age; it occurs in 3% of people less than 60 years, but its prevalence increased to 15% to 20% among individuals greater than 70 years in 2017 globally. According to the World Health Organization, by 2050, the world’s population aged 60 years and older is expected to be 2 billion, up from 900 million in 2015. Furthermore, Eurostat estimated that over 19.2% of the population in Europe was aged 65 and above in 2018.

This rise in the aging population will lead to a rise in PAD cases which will eventually lead to growth in the peripheral artery disease market.

Market Opportunities

Developing economies pose an opportunity for various markets as they have undeveloped research & development sector owing to which they are unable to address upcoming health challenges. In spite of huge demand, the African region is dependent on imported medicines and other health technologies. Although there is a high requirement of treatment, poor economic conditions lead to the slow growth of the healthcare industry within the African region. The National Center for Biotechnology Information stated that Peripheral artery disease (PAD), affected approximately 202 million people worldwide in 2019, among which more than two-thirds reside in low- and middle-income countries (LMIC). Moreover, The Lancet stated that peripheral artery disease remains largely undiagnosed and untreated worldwide because a large proportion of patients have the asymptomatic disease.

Hence the rising need for the treatment of peripheral artery disease in developing economies act as an opportunity for the growth of the market.

Market Restraints

A product recall is a request to return a product after the discovery of safety issues or product defects that might endanger the consumer or put the maker/seller at risk of legal action. Product recalls of devices meant for peripheral artery disease by the FDA has led to a dip in the growth of the peripheral artery disease market. For instance, the Food and Drug Administration (FDA) has issued a safety alert regarding the increased risk of death associated with the use of paclitaxel-coated balloons and paclitaxel-eluting stents for the treatment of peripheral arterial disease (PAD).

Additionally, Bard Peripheral Vascular sent an urgent Class I medical device recall notification for its LifeStent Solo vascular stent. This stent caused serious health consequences, including possible complications of bleeding, loss of limb, heart attack, stroke, vascular surgery and/or death. Similar product recalls during the forecast period are likely to hamper market growth.

Strategic Outlook and Future Directions

Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.

Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.

Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.

Market Value by Segment (2025)

Value (USD Mn)
Hospitals and Clinics
Ambulatory Surgery Centers
End User_Others

Companies

Key companies profiled in Peripheral Artery Disease Market

Profiles of 107 companies operating in the Peripheral Artery Disease Market market, including revenue, employee count, and market positioning where available.

Showing 107 of 107 companies

Biotronik

Biotronik

Healthcare

Company Headquarters: Berlin, Germany Founded: 1963 Workforce: ~9,000 Company Working: Biotronik is a leading global medical device company with products and services that improve and save the lives of patients suffering from endovascular and cardiovascular diseases. The company’s technologies enable physicians around the world to provide patients the highest standard of care. Its medical devices are created by engineers and designers in Germany, the US, Switzerland, and Singapore. The company is a Golden Goose in the US because of its medium to strong market share, strong profit margins, and slower revenue growth than some of its competitors in the Medical Device Manufacturing industry, where it accounts for an estimated 0.5% of total industry revenue. The company research, develops, and manufactures in technologically advanced countries, including Germany, Switzerland, the US, and Singapore.

RevenueN/A
Employees9,000
Market CapN/A
Founded1962
Berlin, Germany
Cardinal H

Cardinal Health

Healthcare

Company Headquarters: Ohio, US Founded: 1971 Workforce: ~50,000 Company Working: Cardinal Health is a global, integrated healthcare services and products company. The firm provides customized solutions for hospitals, health systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physicians’ offices worldwide. It operates through two business segments, namely, medical products and pharmaceuticals. Through these segments, it offers cost-effective solutions that enhance the supply chain efficiency from hospital to home. It connects patients, providers, payers, pharmacists, and manufacturers for integrated care coordination and better patient management. Through its services and products, it serves nearly 85% of hospitals, more than 26,000 pharmacies, and more than 10,000 specialty physician offices and clinics across the US. In the fiscal year 2018, nearly 50,000 global employees operated in more than 46 countries.

Revenue$121.5B
Employees50,000
Market CapN/A
Founded1970
Ohio, US
Cook Group

Cook Group

Healthcare

Cook Group, a privately held company, operates in the global nephrectomy market through its sub-subsidiary Cook Medical Incorporated (Cook). It is involved in the development of surgical technologies. The company has multiple categories of a wide range of surgical products and services. The company is focused on developing products minimally invasive surgical procedures. The company mainly operates through the vascular and MedSurg divisions. The MedSurg division comprises of surgery, critical care, urology, and others. The company has a strong presence in the Americas, Europe, Asia, and other regions.

RevenueN/A
EmployeesN/A
Market CapN/A
FoundedN/A
United States, North America
Terumo Med

Terumo Medical Corporation

Healthcare

Company Headquarters: Tokyo, Japan Founded: 1921 Workforce: 25,000 Company Working: Terumo Medical Corporation delivers innovative health solutions and provides breakthrough solutions and technologies. The company is involved in manufacturing and sales of medical products and equipment, such as pharmaceuticals, nutritional food supplements, disposable medical devices, vascular grafts, and blood glucose monitoring systems, among others. It has a market presence in over 160 countries in the world. It operates its business through three segments, namely, cardiac and vascular company, blood management company, and general hospital company. Terumo Interventional Systems (TIS), a division of Terumo Medical Corporation, is a market leader in minimally invasive entry site management, lesion access, and interventional technologies. TIS offers a complete, solution-based product portfolio used in advanced coronary, peripheral endovascular and urological treatments with strategic initiatives in Transradial Access, Complex Coronary Intervention, Peripheral Artery Disease and Embolotherapy.

Revenue$4.2B
Employees25,000
Market CapN/A
Founded1920
Tokyo, Japan
Koninklijk

Koninklijke Philips NV

Healthcare

Company Headquarters: Amsterdam, Netherlands Founded: 1891 Workforce: 77,000 (2018) Company Working: Koninklijke Philips NV (Philips) is a market leader in healthcare technology. The company has a strong sales and distribution network worldwide and operates in more than 100 countries. Philips offers products through segments, including medical devices, health systems, cardiology, health tech, oncology, respiratory, fertility, and pregnancy. The company deals in maternity care, child care, and oral healthcare products; male grooming and beauty products; food preparation and home care products; and sleep and respiratory care products. It delivers diagnostic X-ray, integrated clinical, magnetic resonance imaging, computed tomography, and molecular imaging solutions. Moreover, the company also offers healthcare information technology, clinical, and visualization and quantification informatics solutions for radiology, cardiology, and oncology; universal data management solutions, picture archiving and communication systems, and integrated electronic medical record systems; clinical and hospital IT platforms; technology-enabled monitoring and intervention, actionable program, cloud-based, and population health management software solutions. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013.

Revenue$18.5B
Employees77,000
Market CapN/A
Founded1890
Amsterdam, Netherlands
Boston Sci

Boston Scientific Corporation

Healthcare

Company Headquarters: Massachusetts, US Founded: 1979 Workforce: ~36,000 Company Working: Boston Scientific Corporation is a worldwide developer, manufacturer, and marketer of medical devices used in a range of interventional medical specialties. The company collaborates with healthcare professionals to develop a broad portfolio of meaningful innovations that improve outcomes, reduce costs, and increase efficiencies. Its product portfolio is majorly divided into endoscopy, interventional cardiology, neuromodulation, peripheral interventions, rhythm management, and urology & pelvic health. In addition, Boston Scientific serves hospitals, clinics, outpatient facilities and medical offices across the world. Boston Scientific Corporation's manufacturing facilities are located across Malaysia, the US, and Ireland. Apart from this, it has a presence in countries like Japan, the Netherlands, France, Poland, India, China, Turkey, South Africa, and Singapore.

Revenue$8.4B
Employees36,000
Market CapN/A
Founded1978
Massachusetts, US
Page 1 of 18
Go to page

About the Author

Healthcare Research Team

Healthcare

Our healthcare desk at Wantstats is staffed by a mix of clinical-market analysts and a senior researcher who track drug approvals, device launches, and provider economics as they happen — not just at reporting time. Every figure in this report is checked against primary interviews, regulatory filings, and our own proprietary datasets before it goes to print.

Powering the world's best teams.
From next-gen startups to established enterprises.

Google logo
Amazon logo
Microsoft logo
Intel logo
Neste logo
McKinsey & Company logo
Deloitte logo
Accenture logo
Oracle logo
PWC logo
EY logo
Honeywell logo

What our clients say

Trusted by forward-thinking businesses
for data-driven intelligence

Noah Malgeri
Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Joseph Aguayo
Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.
Peter Groot Koerkamp
Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.
Younghwan Choi
Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Noah Malgeri
Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Joseph Aguayo
Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.
Peter Groot Koerkamp
Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.
Younghwan Choi
Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.

Peripheral Artery Disease Market

Starting from
$4,950